PerpEquities

Moderna, Inc. (MRNA) balance sheet

NASDAQ · Healthcare · Biotechnology · 4,700 employees · CEO Stéphane Bancel

Price
$221.72 -0.47%
Market cap
$88.5B
Enterprise value
$88.1B
Last report
Q2 '26 filed 2026-07-31
Next report
2026-11-06

At the end of Q2 '26 Moderna, Inc. (MRNA) held $5.14B in cash and short-term investments against $1.29B of debt incl. leases. Total assets $11B, total liabilities $4.2B, shareholders' equity $6.76B.

Balance sheet

Balance sheetTrendQ3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Assets
Cash & equivalents$2.93B$2.91B$2.05B$2.48B$1.64B$1.93B$1.62B$1.28B$1.13B$2.6B$1.91B$1.72B
Short-term investments$4.64B$5.7B$6.47B$6.01B$5.22B$5.1B$4.35B$3.85B$3.37B$3.2B$3.3B$3.42B
Receivables$2.15B$1.08B$387M$423M$1.84B$592M$306M$457M$1.39B$284M$147M$103M
Inventory$487M$202M$295M$399M$412M$117M$128M$240M$332M$153M$146M$280M
Other current assets$96M$88M$68M$31M$46M$58M$69M$57M$132M$45M$141M$148M
Current assets$10.8B$10.3B$9.6B$9.66B$9.67B$8.1B$6.77B$6.17B$6.6B$6.54B$5.77B$5.82B
Property, plant & equipment (net)$2.72B$2.66B$2.76B$2.97B$3.17B$2.96B$2.96B$2.92B$2.86B$2.85B$2.79B$2.76B
Long-term investments$5.36B$4.74B$3.69B$2.36B$2.36B$2.51B$2.42B$2.38B$2.25B$2.34B$2.41B$1.93B
Goodwill$52M$52M$52M$52M$52M$52M$52M$52M$52M$52M$52M$52M
Intangible assets$45M$44M$43M$42M$41M$40M$49M$48M$47M$45M$116M$109M
Deferred tax assets$0$81M$81M$81M$81M$81M$81M$81M$81M$81M$82M$82M
Other non-current assets$478M$523M$502M$516M$440M$407M$368M$359M$241M$421M$263M$213M
Non-current assets$8.65B$8.1B$7.13B$6.02B$6.14B$6.04B$5.94B$5.84B$5.54B$5.79B$5.72B$5.15B
Total assets$19.5B$18.4B$16.7B$15.7B$15.8B$14.1B$12.7B$12B$12.1B$12.3B$11.5B$11B
Liabilities
Accounts payable$494M$520M$183M$279M$373M$405M$226M$175M$267M$317M$161M$167M
Accrued expenses$1.79B$997M$727M$592M$729M$745M$544M$482M$310M$0$108M$192M
Short-term debt$0$0$0$0$0$0$0$0$48M$0$50M$52M
Taxes payable$56M$63M$52M$7M$4M$3M$0$0$0$0$0$0
Deferred revenue$1.37B$568M$559M$702M$379M$153M$125M$218M$163M$99M$102M$295M
Other current liabilities$491M$842M$834M$758M$665M$863M$666M$654M$893M$1.57B$1.97B$1.83B
Current liabilities$4.39B$3.02B$2.38B$2.36B$2.2B$2.21B$1.6B$1.57B$1.68B$1.99B$2.4B$2.53B
Long-term debt$0$0$0$0$0$0$0$0$660M$1.24B$590M$591M
Lease obligations (non-current)$1.27B$1.22B$1.21B$1.24B$1.3B$710M$702M$698M$686M$673M$658M$644M
Deferred revenue (non-current)$166M$83M$58M$95M$95M$58M$58M$65M$157M$153M$154M$147M
Deferred tax liabilities$0$0$0$0$0$0$0$0$239M$0$253M$255M
Other non-current liabilities$172M$256M$262M$266M$276M$267M$274M$276M-$618M-$368M$30M$29M
Non-current liabilities$1.61B$1.56B$1.53B$1.61B$1.68B$1.04B$1.03B$1.04B$1.12B$1.7B$1.69B$1.67B
Total liabilities$6B$4.57B$3.91B$3.97B$3.88B$3.24B$2.64B$2.61B$2.81B$3.69B$4.08B$4.2B
Equity
Retained earnings$13.4B$13.6B$12.4B$11.2B$11.2B$10B$9.07B$8.25B$8.05B$7.22B$5.88B$5.1B
Accumulated other comprehensive income-$211M-$123M-$101M-$71M$11M-$10M$10M$23M$27M$45M$25M$19M
Shareholders' equity$13.5B$13.9B$12.8B$11.7B$11.9B$10.9B$10.1B$9.4B$9.33B$8.65B$7.41B$6.76B
Debt
Total debt (incl. leases)$1.46B$1.24B$1.24B$1.27B$1.36B$747M$745M$741M$1.39B$1.92B$1.3B$1.29B
Net debt (debt - cash)-$1.48B-$1.66B-$814M-$1.21B-$289M-$1.18B-$878M-$538M$261M-$679M-$610M-$436M

Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30

Data as of 2026-11-01